2,5-Dimethoxy-4-methylphenylcyclopropylamine

DMCPA
Names
	Preferred IUPAC name 2-(2,5-Dimethoxy-4-methylphenyl)cyclopropan-1-amine
Identifiers
CAS Number	714903-64-7 ; 69854-49-5 (non-specific) ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL13530 ;
ChemSpider	2285590 ;
PubChem CID	3017965;
UNII	U2YC8RFK7B ;
CompTox Dashboard (EPA)	DTXSID10990120 ;
	InChI InChI=1S/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 Key: HYVPPECPQRBJEQ-UHFFFAOYSA-N ; InChI=1/C12H17NO2/c1-7-4-12(15-3)9(6-11(7)14-2)8-5-10(8)13/h4,6,8,10H,5,13H2,1-3H3 Key: HYVPPECPQRBJEQ-UHFFFAOYAN;
	SMILES O(c1c(cc(OC)c(c1)C2CC2N)C)C;
Properties
Chemical formula	C12H17NO2
Molar mass	207.273 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

2,5-Dimethoxy-4-methylphenylcyclopropylamine (DMCPA) is a lesser-known psychedelic drug and a substituted amphetamine and phenylcyclopropylamine. DMCPA was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 15–20 mg and the duration is listed as 4–8 hours.^[1] DMCPA produces open-eye visuals, anorexia, and psychedelic dreams.^[1] Shulgin gives it a +++ on the Shulgin Rating Scale.^[1]

Pharmacology

Very little data exists about the pharmacological properties, metabolism, and toxicity of DMCPA.